NDC 0069-0235

Cibinqo

Abrocitinib

Cibinqo is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Abrocitinib.

• Product ID: 0069-0235_f14e2164-a8d1-4671-b944-c15ec6bf6196
• NDC: 0069-0235
• Product Type: Human Prescription Drug
• Proprietary Name: Cibinqo
• Generic Name: Abrocitinib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2022-02-24
• Marketing Category: NDA /
• Application Number: NDA213871
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: ABROCITINIB
• Active Ingredient Strength: 50 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0069-0235-30

30 TABLET, FILM COATED in 1 BOTTLE (0069-0235-30)

• Marketing Start Date: 2022-02-24
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Cibinqo" or generic name "Abrocitinib"

NDC	Brand Name	Generic Name
0069-0235	Cibinqo	abrocitinib
0069-0335	Cibinqo	abrocitinib
0069-0435	Cibinqo	abrocitinib
63539-236	CIBINQO	abrocitinib
63539-336	CIBINQO	abrocitinib
63539-436	CIBINQO	abrocitinib